Periodic Reporting for period 2 - DelNAM (Strengthening the Research Area of Delivery of Nucleic acid mimics (NAMS) into bacteria to fight the antibiotic crisis)
Período documentado: 2019-11-01 hasta 2022-01-31
Nucleic Acid Mimics (NAMs) may be the answer to this problem, since they can be designed to recognize and block key bacterial genes. Therefore, depending on the target, NAMs can be used to kill bacteria or to restore bacterial susceptibility to antibiotics, provided they can penetrate bacteria and reach their targets. The penetration of NAMs is, however, limited by the complex bacterial envelope composed of several layers that surround the bacterial cells. As a result, the NAMs need to be delivered across the bacterial envelope.
The DelNAM project aims to develop an innovative solution to fight and solve the crisis of bacterial resistance to antibiotics, through the delivery of NAMs into bacteria. In addition, DelNAM aims to position the consortium as leaders in the application of NAMs and delivery vehicles to combat bacterial resistance to antibiotics, raise public awareness concerning this problem, and train the Portuguese institution’s research staff in emergent technologies and interface science areas.
The group has organized and participated in several events, with the objective of disseminating results and increasing DelNAM’s contact network. Furthermore, several companies and research groups have been contacted in order to promote future collaborations, aiming to improve the exploitation of the project and its results, as well as seeking a future translation into the industry. The team has also been responsible for regular communications on social media platforms and the project’s website, with the intention to maximize DelNAM’s impact, reaching not only the scientific community but the general public as well.
In order to improve the researchers’ skills in the study area, the group has developed and supervised research projects, as well as encouraged the participation in external conferences, to promote the attainment of shared knowledge. Additionally, several training actions have been organized to facilitate improvement of the members’ competences in science communication and knowledge valorization.
Lastly, the team has been successful in the monitoring and the coordinating of tasks, putting corrective measures in practice when necessary, and has ensured compliance with the set-out ethics requirements.
In terms of the scientific and social impact, a number of measures have already taken effect. Several publications, prepared in the scope of the DelNAM project, have been accepted and are currently in press. Additionally, researchers have been integrated in the UPORTO team under the DelNAM research area, under research grants or doctoral programs, leading to an increase in their qualifications and the enhancement of the research & development activities at UPORTO. Social networks and the group’s events have been used as a way to raise awareness towards antimicrobial resistance not only in the scientific community, but in the general public as well. While measures such as intellectual property protection and the creation of new business models are out of reach for now, given the current technology readiness level (TRL) of the project, these goals remain in DelNAM’s horizon. As such, a particular effort has been made to expand the DelNAM network and to participate in actions related to the valorization of results, towards facilitating the transition of the project’s research to a marketable product to fight antimicrobial resistance.